PubMed Health⌕ Search

PubMed · 15718764

BrainTrain: brain simulator for medical VR application.

Abstract

The brain is known as the most complex organ in the human body. Due to its complexity, learning and understanding the anatomy and functions of the cerebral cortex without effective learning assistance is rather difficult for medical novices and students in health and biological sciences. In this paper, we present a new virtual reality (VR) simulator for neurological education and neurosurgery. The system is based on a new three-dimensional (3D) user-computer interface design with a tangible object and a force-torque sensor. The system is combined with highly interactive computer-generated graphics and acoustics to provide multi-modal interactions through the user's sensory channels (vision, tactile, haptic and auditory). The system allows the user to feel the simulated object from its physical model that formed the interface device, while exploring or interacting with the mimicked computer-generated object in the virtual environment (VE). Unlike other passive interface devices, our system can detect the position and orientation of the interacting force in real-time, based on the system's set-up and a force-torque data acquisition technique. As long as the user is touching the model, the positions of the user's fingertip in the VE can be determined and is synchronized with the finger's motion in the physical world without requirement of an additional six-degree-of-freedom tracking device. The prior works have shown the use of the system set-up in medical applications. We demonstrate the system for neurological education and neurosurgery as a recent application. The main functions of the simulator contribute to education in neuroanatomy and visualization for diagnostic and pre-surgery planning. Once the user has touched the model, the system will mark the associated anatomy region and will provide the information of the region in terms of text note and/or sound. The user can switch from anatomy to the brain's function module, which will give details of motor, sensory or other cortical functions associated to the touch areas. In addition, the user can generate and visualize arbitrary cross-sectional images from corresponding to the magnetic resonance imaging (MRI) datasets either for training or for diagnostic purpose. The user can manipulate the cross-section image interactively and intuitively by moving the finger on the interface device.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bundit Panchaphongsaphak, Rainer Burgkart, Robert Riener. 2005. BrainTrain: brain simulator for medical VR application.. https://pubmed.ncbi.nlm.nih.gov/15718764/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗